Updated 6 February 2008



Additional Files, Table 1. Characteristics of HIV-infected tuberculosis patients, stratified by vital status at the end of tuberculosis treatment.

|Characteristics and clinical features |All patients |Survived |Died†† |p |

|  |(n=667) |(n=555) |(n=112) | |

|  |N |% |

|  |Rate†† |95% CI |Rate†† |95% CI |

|  |  |Lower |

|  |HR |95% CI |HR |95% CI |

|  |  |Lower |Upper |

| | | |NVP (n=147) |EFV (n=113) |

| |

|Comparison groups |All patients |Bacteriologic-confirmed TB (n=301) |

| |(n=432) | |

| | | |HR |95% CI |HR |95% CI |

|  |  |  |  |

|Comparison groups |All patients |Bacteriological-confirmed TB (n=272) |

| |(n=397) | |

| | | |HR |95% CI |HR |95% CI |

  |  |  |  |Lower |Upper |  |Lower |Upper | |Nevirapine |vs. |no ART |0.08 |0.02 |0.28 |0.09 |0.03 |0.33 | |Efavirenz |vs. |no ART |0.32 |0.13 |0.83 |0.05 |0.01 |0.34 | |Nevirapine |vs. |Efavirenz |0.26 |0.06 |1.11 |2.03 |0.19 |21.69 | |

TB, tuberculosis, HIV, human immunodeficiency virus; HR, hazard ratio; CI, confidence interval; ART, anti-retroviral therapy; bold type indicates statistical significance (p ................
................

In order to avoid copyright disputes, this page is only a partial summary.

Google Online Preview   Download